AMPK orchestrates an elaborate cascade protecting tissue from fibrosis and aging
Related Experiment Video
Updated: Feb 26, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Shuai Jiang1, Tian Li2, Zhi Yang2
1Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education. Faculty of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an 710069, China; Department of Aerospace Medicine, The Fourth Military Medical University, 169 Changle West Road, Xi'an 710032, China.
Abstract:
Fibrosis is a common process characterized by excessive extracellular matrix (ECM) accumulation after inflammatory injury, which is also a crucial cause of aging. The process of fibrosis is involved in the pathogenesis of most diseases of the heart, liver, kidney, lung, and other organs/tissues. However, there are no effective therapies for this pathological alteration. Annually, fibrosis represents a huge financial burden for the USA and the world. 5'-AMP-activated protein kinase (AMPK) is a pivotal energy sensor that alleviates or delays the process of fibrogenesis. In this review, we first present basic background information on AMPK and fibrogenesis and describe the protective roles of AMPK in three fibrogenic phases. Second, we analyze the protective action of AMPK during fibrosis in myocardial, hepatic, renal, pulmonary, and other organs/tissues. Third, we present a comprehensive discussion of AMPK during fibrosis and draw a conclusion. This review highlights recent advances, vital for basic research and clinical drug design, in the regulation of AMPK during fibrosis.
Insights
Fibrosis, a major cause of aging and organ damage, lacks effective treatments. This review explores how 5'-AMP-activated protein kinase (AMPK) can combat fibrogenesis, offering hope for new therapies.
Area of Science:
- Biomedical Science
- Pathology
- Molecular Biology
Background:
- Fibrosis, excessive extracellular matrix accumulation, underlies aging and most organ diseases.
- Current therapies for fibrosis are limited, posing a significant global health and economic burden.
- 5 -AMP-activated protein kinase (AMPK) acts as an energy sensor with potential anti-fibrotic properties.
Purpose of the Study:
- To review the protective roles of AMPK in fibrogenesis.
- To analyze AMPK's action in fibrosis across various organs (myocardial, hepatic, renal, pulmonary).
- To discuss recent advances in AMPK regulation for fibrosis treatment.
Main Methods:
- Literature review of existing research on AMPK and fibrosis.
- Analysis of AMPK's involvement in different fibrotic phases and organs.
- Synthesis of current knowledge for future drug development.
Main Results:
- AMPK demonstrates protective effects against fibrogenesis.
- AMPK's anti-fibrotic mechanisms are relevant across multiple organ systems.
- Understanding AMPK regulation is key for developing novel anti-fibrotic therapies.
Conclusions:
- AMPK plays a crucial role in mitigating fibrosis.
- Targeting AMPK offers a promising therapeutic strategy for various fibrotic diseases.
- This review provides insights for basic research and clinical drug design in fibrosis.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade

